Chapter/Section Purchase

1 Introduction to Research & Analysis Reports
1.1 Gene Engineered Subunit Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Gene Engineered Subunit Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Gene Engineered Subunit Vaccine Overall Market Size
2.1 Global Gene Engineered Subunit Vaccine Market Size: 2021 VS 2028
2.2 Global Gene Engineered Subunit Vaccine Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Gene Engineered Subunit Vaccine Players in Global Market
3.2 Top Global Gene Engineered Subunit Vaccine Companies Ranked by Revenue
3.3 Global Gene Engineered Subunit Vaccine Revenue by Companies
3.4 Top 3 and Top 5 Gene Engineered Subunit Vaccine Companies in Global Market, by Revenue in 2021
3.5 Global Companies Gene Engineered Subunit Vaccine Product Type
3.6 Tier 1, Tier 2 and Tier 3 Gene Engineered Subunit Vaccine Players in Global Market
3.6.1 List of Global Tier 1 Gene Engineered Subunit Vaccine Companies
3.6.2 List of Global Tier 2 and Tier 3 Gene Engineered Subunit Vaccine Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Gene Engineered Subunit Vaccine Market Size Markets, 2021 & 2028
4.1.2 Therapeutic Gene Engineered Subunit Vaccine
4.1.3 Preventative Gene Engineered Subunit Vaccine
4.2 By Type - Global Gene Engineered Subunit Vaccine Revenue & Forecasts
4.2.1 By Type - Global Gene Engineered Subunit Vaccine Revenue, 2017-2022
4.2.2 By Type - Global Gene Engineered Subunit Vaccine Revenue, 2023-2028
4.2.3 By Type - Global Gene Engineered Subunit Vaccine Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Gene Engineered Subunit Vaccine Market Size, 2021 & 2028
5.1.2 Human Use
5.1.3 Veterinary Use
5.2 By Application - Global Gene Engineered Subunit Vaccine Revenue & Forecasts
5.2.1 By Application - Global Gene Engineered Subunit Vaccine Revenue, 2017-2022
5.2.2 By Application - Global Gene Engineered Subunit Vaccine Revenue, 2023-2028
5.2.3 By Application - Global Gene Engineered Subunit Vaccine Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Gene Engineered Subunit Vaccine Market Size, 2021 & 2028
6.2 By Region - Global Gene Engineered Subunit Vaccine Revenue & Forecasts
6.2.1 By Region - Global Gene Engineered Subunit Vaccine Revenue, 2017-2022
6.2.2 By Region - Global Gene Engineered Subunit Vaccine Revenue, 2023-2028
6.2.3 By Region - Global Gene Engineered Subunit Vaccine Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Gene Engineered Subunit Vaccine Revenue, 2017-2028
6.3.2 US Gene Engineered Subunit Vaccine Market Size, 2017-2028
6.3.3 Canada Gene Engineered Subunit Vaccine Market Size, 2017-2028
6.3.4 Mexico Gene Engineered Subunit Vaccine Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Gene Engineered Subunit Vaccine Revenue, 2017-2028
6.4.2 Germany Gene Engineered Subunit Vaccine Market Size, 2017-2028
6.4.3 France Gene Engineered Subunit Vaccine Market Size, 2017-2028
6.4.4 U.K. Gene Engineered Subunit Vaccine Market Size, 2017-2028
6.4.5 Italy Gene Engineered Subunit Vaccine Market Size, 2017-2028
6.4.6 Russia Gene Engineered Subunit Vaccine Market Size, 2017-2028
6.4.7 Nordic Countries Gene Engineered Subunit Vaccine Market Size, 2017-2028
6.4.8 Benelux Gene Engineered Subunit Vaccine Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Gene Engineered Subunit Vaccine Revenue, 2017-2028
6.5.2 China Gene Engineered Subunit Vaccine Market Size, 2017-2028
6.5.3 Japan Gene Engineered Subunit Vaccine Market Size, 2017-2028
6.5.4 South Korea Gene Engineered Subunit Vaccine Market Size, 2017-2028
6.5.5 Southeast Asia Gene Engineered Subunit Vaccine Market Size, 2017-2028
6.5.6 India Gene Engineered Subunit Vaccine Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Gene Engineered Subunit Vaccine Revenue, 2017-2028
6.6.2 Brazil Gene Engineered Subunit Vaccine Market Size, 2017-2028
6.6.3 Argentina Gene Engineered Subunit Vaccine Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Gene Engineered Subunit Vaccine Revenue, 2017-2028
6.7.2 Turkey Gene Engineered Subunit Vaccine Market Size, 2017-2028
6.7.3 Israel Gene Engineered Subunit Vaccine Market Size, 2017-2028
6.7.4 Saudi Arabia Gene Engineered Subunit Vaccine Market Size, 2017-2028
6.7.5 UAE Gene Engineered Subunit Vaccine Market Size, 2017-2028
7 Players Profiles
7.1 Merck
7.1.1 Merck Corporate Summary
7.1.2 Merck Business Overview
7.1.3 Merck Gene Engineered Subunit Vaccine Major Product Offerings
7.1.4 Merck Gene Engineered Subunit Vaccine Revenue in Global Market (2017-2022)
7.1.5 Merck Key News
7.2 GSK
7.2.1 GSK Corporate Summary
7.2.2 GSK Business Overview
7.2.3 GSK Gene Engineered Subunit Vaccine Major Product Offerings
7.2.4 GSK Gene Engineered Subunit Vaccine Revenue in Global Market (2017-2022)
7.2.5 GSK Key News
7.3 Tiantan
7.3.1 Tiantan Corporate Summary
7.3.2 Tiantan Business Overview
7.3.3 Tiantan Gene Engineered Subunit Vaccine Major Product Offerings
7.3.4 Tiantan Gene Engineered Subunit Vaccine Revenue in Global Market (2017-2022)
7.3.5 Tiantan Key News
7.4 Pulike
7.4.1 Pulike Corporate Summary
7.4.2 Pulike Business Overview
7.4.3 Pulike Gene Engineered Subunit Vaccine Major Product Offerings
7.4.4 Pulike Gene Engineered Subunit Vaccine Revenue in Global Market (2017-2022)
7.4.5 Pulike Key News
7.5 Greffex
7.5.1 Greffex Corporate Summary
7.5.2 Greffex Business Overview
7.5.3 Greffex Gene Engineered Subunit Vaccine Major Product Offerings
7.5.4 Greffex Gene Engineered Subunit Vaccine Revenue in Global Market (2017-2022)
7.5.5 Greffex Key News
7.6 CureVac
7.6.1 CureVac Corporate Summary
7.6.2 CureVac Business Overview
7.6.3 CureVac Gene Engineered Subunit Vaccine Major Product Offerings
7.6.4 CureVac Gene Engineered Subunit Vaccine Revenue in Global Market (2017-2022)
7.6.5 CureVac Key News
7.7 Yebio
7.7.1 Yebio Corporate Summary
7.7.2 Yebio Business Overview
7.7.3 Yebio Gene Engineered Subunit Vaccine Major Product Offerings
7.7.4 Yebio Gene Engineered Subunit Vaccine Revenue in Global Market (2017-2022)
7.7.5 Yebio Key News
7.8 Sanofi Pasteur SA
7.8.1 Sanofi Pasteur SA Corporate Summary
7.8.2 Sanofi Pasteur SA Business Overview
7.8.3 Sanofi Pasteur SA Gene Engineered Subunit Vaccine Major Product Offerings
7.8.4 Sanofi Pasteur SA Gene Engineered Subunit Vaccine Revenue in Global Market (2017-2022)
7.8.5 Sanofi Pasteur SA Key News
7.9 Virbac
7.9.1 Virbac Corporate Summary
7.9.2 Virbac Business Overview
7.9.3 Virbac Gene Engineered Subunit Vaccine Major Product Offerings
7.9.4 Virbac Gene Engineered Subunit Vaccine Revenue in Global Market (2017-2022)
7.9.5 Virbac Key News
7.10 Pfizer Inc.
7.10.1 Pfizer Inc. Corporate Summary
7.10.2 Pfizer Inc. Business Overview
7.10.3 Pfizer Inc. Gene Engineered Subunit Vaccine Major Product Offerings
7.10.4 Pfizer Inc. Gene Engineered Subunit Vaccine Revenue in Global Market (2017-2022)
7.10.5 Pfizer Inc. Key News
7.11 Walvax Biotechnology
7.11.1 Walvax Biotechnology Corporate Summary
7.11.2 Walvax Biotechnology Business Overview
7.11.3 Walvax Biotechnology Gene Engineered Subunit Vaccine Major Product Offerings
7.11.4 Walvax Biotechnology Gene Engineered Subunit Vaccine Revenue in Global Market (2017-2022)
7.11.5 Walvax Biotechnology Key News
7.12 Kontec
7.12.1 Kontec Corporate Summary
7.12.2 Kontec Business Overview
7.12.3 Kontec Gene Engineered Subunit Vaccine Major Product Offerings
7.12.4 Kontec Gene Engineered Subunit Vaccine Revenue in Global Market (2017-2022)
7.12.5 Kontec Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer